Novo Nordisk A/S
A ‘perfect storm’ has set this sector up to benefit if Trump’s tariffs go ahead, Bank of America says
U.S. President Donald Trump’s tariffs regime has rocked international markets in recent weeks, sparking massive selloffs and rallies in stocks across the globe. Certain tariff-sensitive stocks, such as those in the autos, mining and pharmaceuticals sectors, have seen particularly volatile trade. In a Wednesday ruling , however, the U.S. Court of International Trade blocked the […]
Read More
Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs
Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images Only half of health insurer Cigna‘s clients currently cover the popular GLP-1 weight loss drugs Wegovy and Zepbound because of their high costs. But the company’s pharmacy benefits unit Evernorth has reached a deal with […]
Read More
Novo Nordisk’s future in doubt after Wegovy maker’s ‘surprise’ CEO ouster
Novo Nordisk’s ousting of longtime CEO Lars Fruergaard Jørgensen bemused analysts, with many questioning the future of the Wegovy obesity drug maker. Source
Read More
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly
A view of the logo of Novo Nordisk at the company’s office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Tom Little | Reuters Novo Nordisk is banking on fresh leadership to help it reclaim the crown in the booming weight loss drug market. The Danish drugmaker on Friday abruptly announced that […]
Read More
This money manager won’t follow Warren Buffett’s path with these two stocks Berkshire’s buying
New regulatory filings showed that Warren Buffett ‘s Berkshire Hathaway doubled its position in beer and wine producer Constellation Brands last quarter. But at least one investor doesn’t agree with the “Oracle of Omaha’s” investment. Main Street Research’s Chief Investment Officer James Demmert joined CNBC’s ” Power Lunch ” on Friday to offer his take […]
Read More
Stocks making the biggest moves midday: Applied Materials, Novo Nordisk, Cava, Vistra and more
Check out the companies making headlines in midday trading. Applied Materials — Shares of the semiconductor manufacturer dropped 6% after Applied Materials posted disappointing fiscal second-quarter revenue. The company’s revenue of $7.10 billion was below the LSEG consensus of $7.13 billion. Semiconductor revenue of $5.26 billion also disappointed the $5.31 billion analysts were looking for. […]
Read More
Stocks making the biggest moves premarket: Charter Communications, Doximity, Novo Nordisk and more
Check out the companies making headlines before the bell. Charter Communications — The cable stock rose 7% after Charter agreed to merge with rival Cox Communications . The combined company will change its name to Cox Communications within a year. Constellation Brands — Shares popped 3.4% after Berkshire Hathaway disclosed doubled its stake in the […]
Read More
Novo Nordisk CEO to step down as competition weighs on Wegovy maker’s share price
Novo Nordisk CEO Lars Jorgensen testifies before a Senate Health, Education, Labor, and Pensions Committee hearing on U.S. prices for the weight loss drugs Ozempic and Wegovy, on Capitol Hill in Washington, U.S., September 24, 2024. Piroschka Van De Wouw | Reuters Novo Nordisk CEO Lars Fruergaard Jørgensen is stepping down, the Wegovy-maker said Friday, […]
Read More
Denmark’s economy boomed on drug exports — Trump’s tariffs threat won’t be what slows it down
Vials move along a conveyor at the Novo Nordisk A/S production facilities in Hillerod, Denmark, on Monday, June 12, 2023. The success of Novo’s bestsellers Ozempic and Wegovy, drugs that help people lose significant amounts of weight, has created something of a gold rush in the pharma industry with about 40 companies developing products that […]
Read More
Why Americans pay so much more for prescription drugs
In a photo illustration, prescription drugs are seen next to a pill bottle on July 23, 2024 in New York City. Spencer Platt | Getty Images News | Getty Images President Donald Trump’s latest bid to slash prescription drug prices has once again stirred heated debate about the high costs paid by U.S. patients. The […]
Read More